Lisata Therapeutics (LSTA) Earnings Date, Estimates & Call Transcripts $2.52 -0.01 (-0.43%) As of 03:15 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lisata Therapeutics Earnings Summary Lisata Therapeutics announced Q2 2025 earnings on August 7, 2025, reporting an EPS of -$0.54, which beat analysts' consensus estimates of -$0.65 by $0.11. Quarterly revenue was reported to be $0.07 million. With a trailing EPS of -$2.23, Lisata Therapeutics' earnings are expected to grow next year, from ($2.66) to ($2.36) per share. Latest Q2 Earnings DateAug. 7EstimatedConsensus EPS (Aug. 7) -$0.65 Actual EPS (Aug. 7) -$0.54 Beat By $0.11 Actual Revenue (Aug. 7) $0.07MQ2 2025 Earnings ResourcesQ2 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)Powered by Get Lisata Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Lisata Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataLSTA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.LSTA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Lisata Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.74-$0.74-$0.74Q2 20252-$0.66-$0.61-$0.64Q3 20252-$0.67-$0.51-$0.59Q4 20252-$0.79-$0.50-$0.65 Lisata Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025-$0.65-$0.54+$0.11-$0.54-$0.07M5/8/2025Q1 2025-$0.53-$0.55 -$0.02-$0.55--2/27/2025Q4 2024-$0.76-$0.55+$0.21-$0.55-$1.00M11/12/2024Q3 2024-$0.75-$0.59+$0.16-$0.59--8/12/2024Q2 2024-$0.75-$0.61+$0.14-$0.61--5/9/2024Q1 2024-$0.73-$0.65+$0.08-$0.65--2/29/2024Q4 2023-$0.86-$0.66+$0.20-$0.66--11/2/2023Q3 2023-$0.93-$0.65+$0.28-$0.65-- Lisata Therapeutics Earnings - Frequently Asked Questions When did Lisata Therapeutics announce their last quarterly earnings? Lisata Therapeutics (NASDAQ:LSTA) last announced its quarterly earning data on Thursday, August 7, 2025. Learn more on LSTA's earnings history. Did Lisata Therapeutics beat their earnings estimates last quarter? In the previous quarter, Lisata Therapeutics (NASDAQ:LSTA) reported ($0.54) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.65) by $0.11. Learn more on analysts' earnings estimate vs. LSTA's actual earnings. How can I listen to Lisata Therapeutics' earnings conference call? The conference call for Lisata Therapeutics' latest earnings report can be listened to online. Listen to Conference Call How can I read Lisata Therapeutics' conference call transcript? The conference call transcript for Lisata Therapeutics' latest earnings report can be read online. Read Transcript How much revenue does Lisata Therapeutics generate each year? Lisata Therapeutics (NASDAQ:LSTA) has a recorded annual revenue of $1 million. How much profit does Lisata Therapeutics generate each year? Lisata Therapeutics (NASDAQ:LSTA) has a recorded net income of -$19.99 million. LSTA has generated -$2.23 earnings per share over the last four quarters. What is Lisata Therapeutics' EPS forecast for next year? Lisata Therapeutics' earnings are expected to grow from ($2.66) per share to ($2.36) per share in the next year. More Earnings Resources from MarketBeat Related Companies TScan Therapeutics Earnings Results Invivyd Earnings Results MacroGenics Earnings Results ImmunoPrecise Antibodies Earnings Results XBiotech Earnings Results VistaGen Therapeutics Earnings Results Entera Bio Earnings Results Milestone Pharmaceuticals Earnings Results Oramed Pharmaceuticals Earnings Results Surrozen Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Green Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost PressuresWhy BigBear.ai Stock's Dip on Earnings Can Be an Opportunity CrowdStrike Faces Valuation Test Before Key Earnings ReportPost-Earnings, How Does D-Wave Stack Up Against Quantum Rivals?Why SoundHound AI's Earnings Show the Stock Can Move Higher This page (NASDAQ:LSTA) was last updated on 8/18/2025 by MarketBeat.com Staff From Our Partners"AI Upgrade" Coming Sept. 1stA new “AI Upgrade” is rolling out on September 1st—and tech leaders are calling it transformational. Softbank’...Behind the Markets | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lisata Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lisata Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access